R&Dplatform

Contact Us

 

 

  

Address: Beijing's xizhimen south street, xicheng district

 

The British garden 1 floor. Room 824

 

Zip code: 100035

 

Telephone: 010-58562339

 

Fax: 010-58562339

 

Email address: cngjzj@163.com

 

Web site (click on the url link directly left) :

 

http://www.cngjzj.com/

 

Blog (click on the url link directly left) :

http://blog.sina.com.Cn/CNGJZJ

 

To xizhimen south street, xicheng district building to the British garden route

L airport line 1

Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.

L airport line 2

From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.

L bus subway near:

106 bus GuanYuan: 107 road, express way

Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road

Che zhuang: subway line two

Xizhimen subway: metro line 2

Buses and attempts: 107 road, 118 road, 701 road

Buses and north zhuang: 209 road, 375 road, 392 road

 

Your position is: Home >> R&Dplatform >> R&Dplatform

The research and development of the Chinese medicine industry will be an important power

2012年04月27日

复制链接 打印 大 中 小

<

 

 

 

The research and development of the Chinese medicine industry will be an important power

 

 

Author: bank consultant

 

 

 

        In recent years, the development of the industry of Chinese medicine by a negative reports influence, especially in the United States of the traditional Chinese medicine enterprise listed related to withdraw from the market, more have triggered the traditional Chinese medicine industry profitability questioned. But bank advisers say, Chinese traditional medicine industry profitability and have not been affected, on the contrary, Chinese traditional medicine the profitability of products is gradually improving. This is because: one of traditional Chinese medicine industry development present asymmetry, traditional Chinese medicine and traditional Chinese medicine yinpian sales accounted for domestic pharmaceutical more than forty percent of the market, the market is very attractive basis; Second, the Chinese medicine products in China, with a large, fixed consumer groups, traditional Chinese medicine consumption has always maintained a rapid growth; Third, the traditional Chinese medicine industry research and development ability decided the overall level of production, prompted a sharp increase output value related, 2010 1 to 12 months, the cumulative yield nearly 2 million tons of traditional Chinese medicine, more than 21.63% increase over the same period in 2009.

 

        Bank consultant consulting YangWenLiu IPO analysts think that the long-term development of the industry of Chinese power market and policy is the double driver. From a policy perspective, traditional Chinese medicine industry is always the key support of the state industry, the "eleventh five-year plan" period, "Chinese medicine Renaissance" become a national strategy, the development of the industry have more policy resources; In February 2009, the state food and drug administration issued by the bureau of the protection of traditional Chinese medicines guiding principle "; In 2010, the central government budget for the special fund 5.243 billion yuan for the development of the cause of traditional Chinese medicine. This marks the subsequent market development process, the policy will always maintain the industry development potential.

 

        But, Chinese traditional medicine market really good comes from research and development level of investment promotion, research and development of the traditional Chinese medicine industry in our country will become the important direction of future expansion.

        

        The competition from outside the main body to see, the current global pharmaceutical enterprise top 20 have set up special Chinese herbal medicine research center, some firms have started to traditional Chinese medicine in China r&d talents a snare.

 

        From the internal market competition to see, tongren temple, the tai chi group, hua san-jiu, nine of the big cheese hall of traditional Chinese medicine industry group company has become the leading enterprises, the development of enterprise become the the development of the industry benchmarks. This means that China's traditional Chinese medicine market competition tends to be more oligarchs competition, regional market, subdivision medicinal materials will be available to both the market leader market, decided to China's regional market profitability will appear centralization, grading change wait for a phenomenon. In the policy support ability, the market share of the present situation of relative stability, enterprise potential scientific research ability will become the selection of traditional Chinese medicine can be investment enterprise key standards.

 

        Traditional Chinese medicine for edible of basic and clinical efficacy, determine that it has a large market potential and development space, and therefore attracted numerous market from main body. In addition to the drug treatment, Chinese herbal medicine can also be developed into health food, food, beverage, cosmetics, veterinary medicine, Chinese traditional medicine feed additives, these will lead to greater economic and social benefits, will also be the industry's investment gains bring far more than the current yield profit source. It can be inferred that the traditional Chinese medicine market investment in the future will come from research and development ability of Angle innovation, grasp the development in advance for investment will win a bigger profit in return. (bank consultant)

 

        Source: China medical report